capsule91
Long

a very positive structure with interesting developments

NSE:AUROPHARMA   AUROBINDO PHARMA
303 views
3
the sandoz acquisition, is going to add 50% of the last fy revenue , with balance sheet leveraged to 0.7 de ratio...

disclaimer... not an investing/trading recommendation

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out